Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India
· Delayed Price · Currency is INR 69.20
-1.28 (-1.82%)
At close: Mar 9, 2026
BOM:524412 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,969 | 942 | 1,253 | 601 | 1,051 | 543 | Upgrade
|
| Market Cap Growth | 59.51% | -24.82% | 108.61% | -42.83% | 93.71% | 74.44% | Upgrade
|
| Enterprise Value | 2,457 | 1,314 | 1,553 | 842 | 1,276 | 716 | Upgrade
|
| Last Close Price | 69.20 | 33.71 | 44.68 | 23.67 | 41.40 | 23.20 | Upgrade
|
| PE Ratio | 57.97 | 23.42 | 26.76 | 15.93 | 16.03 | 8.33 | Upgrade
|
| PS Ratio | 0.50 | 0.20 | 0.31 | 0.14 | 0.21 | 0.15 | Upgrade
|
| PB Ratio | 1.32 | 0.68 | 0.94 | 0.51 | 0.93 | 0.55 | Upgrade
|
| P/TBV Ratio | 1.32 | 0.68 | 0.94 | 0.51 | 0.93 | 0.55 | Upgrade
|
| P/FCF Ratio | - | 18.49 | - | - | - | 20.89 | Upgrade
|
| P/OCF Ratio | - | 9.15 | - | - | 210.69 | 9.91 | Upgrade
|
| EV/Sales Ratio | 0.63 | 0.28 | 0.39 | 0.20 | 0.26 | 0.20 | Upgrade
|
| EV/EBITDA Ratio | 98.16 | 18.61 | 13.54 | 10.18 | 10.62 | 7.83 | Upgrade
|
| EV/EBIT Ratio | - | 25.69 | 15.89 | 12.58 | 12.73 | 8.70 | Upgrade
|
| EV/FCF Ratio | - | 25.78 | - | - | - | 27.58 | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.31 | 0.24 | 0.32 | 0.13 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 22.76 | 6.17 | 2.73 | 4.56 | 1.18 | 1.97 | Upgrade
|
| Debt / FCF Ratio | - | 8.55 | - | - | - | 6.94 | Upgrade
|
| Net Debt / Equity Ratio | 0.33 | 0.29 | 0.21 | 0.31 | 0.12 | 0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 19.49 | 5.71 | 2.48 | 4.43 | 1.16 | 1.90 | Upgrade
|
| Net Debt / FCF Ratio | - | 7.91 | -7.66 | -15.74 | -8.21 | 6.69 | Upgrade
|
| Asset Turnover | - | 1.60 | 1.35 | 1.56 | 2.06 | 1.65 | Upgrade
|
| Inventory Turnover | - | 6.43 | 5.57 | 6.66 | 9.16 | 5.49 | Upgrade
|
| Quick Ratio | - | 0.92 | 1.13 | 1.14 | 1.08 | 1.24 | Upgrade
|
| Current Ratio | - | 1.78 | 1.70 | 1.61 | 1.73 | 1.67 | Upgrade
|
| Return on Equity (ROE) | - | 2.97% | 3.74% | 3.26% | 6.17% | 6.81% | Upgrade
|
| Return on Assets (ROA) | - | 1.08% | 2.05% | 1.56% | 2.62% | 2.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.11% | 1.98% | 5.43% | 2.98% | 5.37% | 5.72% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 3.60% | 7.10% | 5.40% | 8.50% | 8.10% | Upgrade
|
| Earnings Yield | 1.74% | 4.27% | 3.74% | 6.28% | 6.24% | 12.01% | Upgrade
|
| FCF Yield | - | 5.41% | -2.96% | -3.87% | -1.62% | 4.79% | Upgrade
|
| Buyback Yield / Dilution | -4.15% | -11.18% | 0.26% | -5.84% | -2.95% | - | Upgrade
|
| Total Shareholder Return | -4.15% | -11.18% | 0.26% | -5.84% | -2.95% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.